Effects of Treatment Intensity on Outcomes in Acquired Apraxia of Speech

American Journal of Speech-language Pathology
Julie L WambaughPatrick J Doyle

Abstract

This investigation was designed to examine the effects of treatment intensity (i.e., dose frequency) on the outcomes of Sound Production Treatment (SPT) for acquired apraxia of speech. Five men with chronic apraxia of speech and aphasia received both intense SPT (3 hr per day/3 days per week) and nonintense/traditional SPT (SPT-T; 1 hr per day/3 days per week) in the context of single-case experimental designs. Each treatment was applied separately to a designated set of experimental words with 1 treatment applied at a time. Twenty-seven treatment sessions were conducted with each phase of treatment. Accuracy of articulation of target sounds within treated and untreated experimental words was measured during the course of the investigation. All participants demonstrated improved articulation with both treatment intensities. Better maintenance of gains for treated items was found with SPT-T for 2 participants as measured at an 8-week posttreatment retention probe. Superior maintenance of increased accuracy of production of untreated items was also observed with SPT-T for all participants. A less intense (distributed) application of SPT facilitated better maintenance of improved articulatory accuracy for untreated items, and in s...Continue Reading

Associated Clinical Trials

References

Aug 1, 1981·The Journal of Speech and Hearing Disorders·K M Yorkston, D R Beukelman
Apr 1, 1993·Journal of Speech and Hearing Research·L E Nicholas, R H Brookshire
Aug 26, 1998·Journal of Speech, Language, and Hearing Research : JSLHR·J L WambaughP J Doyle
Mar 22, 2003·Stroke; a Journal of Cerebral Circulation·Sanjit K BhogalMark Speechley
May 25, 2006·Psychological Bulletin·Nicholas J CepedaDoug Rohrer
Dec 8, 2006·Neuropsychology Review·Pélagie M Beeson, Randall R Robey
Jan 16, 2007·Environmental Microbiology·Achim Schmalenberger, Michael A Kertesz
Feb 28, 2007·Mental Retardation and Developmental Disabilities Research Reviews·Steven F WarrenPaul J Yoder
Jan 31, 2008·Journal of Speech, Language, and Hearing Research : JSLHR·Jeffrey A Kleim, Theresa A Jones
Jul 30, 2008·American Journal of Speech-language Pathology·Edwin MaasRichard A Schmidt
Jul 16, 2010·Journal of Psychosomatic Research·Azmeh ShahidColin M Shapiro
Aug 28, 2010·Journal of Speech, Language, and Hearing Research : JSLHR·Kirrie J BallardJeannie McDonald
Feb 19, 2011·American Journal of Speech-language Pathology·Denice Michelle Edeal, Christina Elke Gildersleeve-Neumann
Oct 17, 2012·American Journal of Speech-language Pathology·Julie L WambaughShannon C Mauszycki
Mar 26, 2013·Memory·Matthew C BellMelody Wiseheart
Aug 1, 2013·Current Treatment Options in Oncology·Myrna R Rosenfeld, Josep Dalmau
Jul 24, 2014·Journal of Communication Disorders·Donna C ThomasKirrie J Ballard
Jan 13, 2015·International Journal of Language & Communication Disorders·Aravind K NamasivayamPascal van Lieshout
Mar 27, 2015·Journal of Speech, Language, and Hearing Research : JSLHR·William D HulaAnn St Jacque
Jul 3, 2015·American Journal of Speech-language Pathology·Dallin J BaileyJulie Wambaugh
Mar 15, 2016·Frontiers in Human Neuroscience·Guillermo BorragánPhilippe Peigneux
Jun 28, 2017·American Journal of Speech-language Pathology·Katarina L HaleyJulie L Wambaugh
Jun 28, 2017·Journal of Speech, Language, and Hearing Research : JSLHR·Julie L WambaughDallin J Bailey

❮ Previous
Next ❯

Citations

Nov 7, 2019·American Journal of Speech-language Pathology·Shannon C Mauszycki, Julie L Wambaugh
Jul 8, 2020·American Journal of Speech-language Pathology·Julie L WambaughChristina Nessler
Mar 25, 2021·American Journal of Speech-language Pathology·Emilia VittiJulie Wambaugh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Speech-language Pathology
Shannon C MauszyckiJulie L Wambaugh
American Journal of Speech-language Pathology
Julie L WambaughShannon C Mauszycki
Journal of Speech, Language, and Hearing Research : JSLHR
Julie L WambaughP J Doyle
© 2022 Meta ULC. All rights reserved